CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 11 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | -66.7% | 1,000 | -66.7% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Avenue Asset Management, LP | 84,878 | $120,000 | 0.01% |
| DIMENSIONAL FUND ADVISORS LP | 13,938 | $20,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,000 | $3,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 21,000 | $29,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 7,229 | $10,000 | 0.00% |
| Citadel Advisors | 26,568 | $38,000 | 0.00% |
| Renaissance Technologies | 71,533 | $102,000 | 0.00% |
| Hilton Capital Management, LLC | 667 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 110,976 | $158,000 | 0.00% |